AzTrials
AzTrials

Rotator Cuff SyndromePhase 2NCT02495818

Suprascapular Nerve Block Guided by Ultrasound

A Phase 2 study testing Lidocaine, Saline solution and Homemade exercises in people with Rotator Cuff Syndrome, run by Marta Imamura at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effect of suprascapular nerve block guided by ultrasound combined with home exercises compared with placebo. Pain intensity, function, pressure pain threshold and goniometry were designed to be assessed in all patients. Read more about this study

Who is it for?
Ages 30 to 60 years
Conditions the study is for
Rotator Cuff Syndrome
What is being tested?
Lidocaine, Saline solution and Homemade exercises
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
87 participants
Where
1 siteBrazil
Study dates
Jun 2013to Jun 2017
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Clinical diagnosis of supraspinatus tendonitis, based on Jobe's lateral test;
  • Pain longer than 1 month prior to screening visit;
  • BMI between 20 and 30 kg/m²;
  • VAS of 4 or higher in screening visit;
  • Ability to understand the questionaires and instructions for home exercises;
  • Signed Informed Consent Form;

Who cannot join

  • History of:
  • Shoulder surgery;
  • Athletic activities;
  • Severe shoulder arthrosis;
  • Diagnosis of total rupture of supraspinatus tendon
  • Autoimmune disease;
Show all 22Show fewer
  • Fracture of humerus, acromion and clavicle
  • Luxation and subluxation of shoulder.
  • Diseases that cause spasticity, such as stroke or spinal cord injury;
  • Systemic alterations that can lead to peripheral neuropathy;
  • Uncontrolled Diabetes or thyroidopathy;
  • Diagnosis of cervical spinal cord injury that results in motor alterations;
  • Allergy or hypersensibility for local or systemic anaesthetics;
  • Coagulopathy;
  • Fibromyalgia according to the 1990 American School of Rheumatology;
  • Uncontrolled psychiatric diseases or controlled psychiatric diseases that need more than two medicines;
  • Acute of chronic renal failure;
  • Pulmonary diseases that presents hypoxemia such as Gold IV Chronic Obstructive Pulmonary Disease or pulmonary fibrosis.
  • Arrhythmia (except isolated supraventricular extrasystoles), coronary failure or functional class 2 or higher heart failure
  • Pregnancy;
  • Use of oral or subcutaneous anticoagulation agent;
  • Patients who fail to comply with the proposed treatment.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Instituto de Medicina Fisica e Reabilitacao HCFMUSP

    São Paulo, 05716-150

Other trials in Brazil

About this study

Official title: Suprascapular Nerve Block Guided by Ultrasound in the Rehabilitation of the Supraspinatus Tendonitis - A Randomized Double Blind Controlled Trial

The purpose of this study is to evaluate the effect of suprascapular nerve block guided by ultrasound combined with home exercises compared with placebo. Pain intensity, function, pressure pain threshold and goniometry were designed to be assessed in all patients.

Read the detailed description

The trial is being carried out in the Institute of Physical Medicine and Rehabilitation of the University of São Paulo since June 2013. The investigators are including patients with clinical diagnosis of supraspinatus tendinitis based on the Lateral Jobe Test.

The patients are being randomized in two arms: Active (2% 5ml lidocaine for suprascapular nerve block and home exercises) and placebo control (saline solution as the nerve block and home exercises). The randomization is being performed in blocks of 4 and 6.

The investigator, the raters, the MD who makes the procedure and the patients are blind to treatment.

4 visits are being performed. Screening and initial evaluation visit, procedure visit, follow up 1 week after intervention and follow up 12 weeks after intervention.

The sample size was estimated to be 54 in each arm.

Being tested
Lidocaine, Saline solution, Homemade exercises
Keywords
Rotator cuff syndrome, supraspinatus tendonitis, suprascapular nerve block, ultrasound guided, supraspinatus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LidocaineProcedure or surgery

    Suprascapular Nerve Block Guided by Ultrasound with 5ml lidocaine at 2%.

  • Saline solutionProcedure or surgery

    Suprascapular Nerve Block Guided by Ultrasound with 5ml saline solution

  • Homemade exercisesOther

    Codman and Hughston exercises.

Study groups in NCT02495818
Study groupRoleWhat they receive
LidocaineExperimentalSuprascapular nerve block with infusion of 5ml lidocaine at 2%, guided by Ultrasound combined with homemade exercises (Codman and Hughston exercises).
Receives: Procedure: Lidocaine; Other: Homemade exercises
Saline solutionSham comparatorIntervention with suprascapular nerve block with 5ml saline solution guided by Ultrasound combined with homemade exercises (Codman and Hughston exercises).
Receives: Procedure: Saline solution; Other: Homemade exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in the score of pain and function as assessed by Shoulder Pain and Disability Index (SPADI)

    Scale for assessing pain and shoulder function.

    Measured: Baseline and one week after intervention

Secondary outcomes (8)
  1. Change from baseline in pain Intensity assessed by Visual Analogue Scale (VAS).

    Self rated pain scale from 0 (no pain) to 10 (the maximum possible pain)

    Measured: Baseline and one week after intervention.

  2. Change from baseline in pain Intensity assessed by Visual Analogue Scale (VAS).

    Self rated pain scale from 0 (no pain) to 10 (the maximum possible pain)

    Measured: Baseline and twelve weeks after intervention.

  3. Change from baseline in the score of pain and function as assessed by SPADI

    Scale for assessing pain and shoulder function.

    Measured: Baseline and 12 weeks after intervention

  4. Change from baseline in Pain Pressure Threshold (PPT) as assessed by Algometry

    Measurement of pain under pressure of the structures of dermatome, myotome and sclerotome corresponding to levels C5 and C6 of spinal cord.

    Measured: Baseline and one week after intervention

  5. Change from baseline in Pain Pressure Threshold (PPT) as assessed by Algometry

    Measurement of pain under pressure of the structures of dermatome, myotome and sclerotome corresponding to levels C5 and C6 of spinal cord.

    Measured: Baseline and twelve weeks after intervention

  6. Change from baseline in Active Range of Motion (AROM) as assessed by Goniometry

    Goniometry for active movements for flexion and abduction of the shoulder

    Measured: Baseline and one week after intervention

  7. Change from baseline in Active Range of Motion (AROM) as assessed by Goniometry

    Goniometry for active movements for flexion and abduction of the shoulder

    Measured: Baseline and twelve weeks after intervention

  8. Safety as assessed by the number of Adverse Events

    Assessment of possible Adverse Events after the intervention

    Measured: 1 week and 12 weeks after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2015 (estimated)
  2. Study startJun 2013
  3. Primary completionMar 2017
  4. Study completionJun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
87 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02495818
Sponsor's protocol ID
Suprascapular Nerve Block
Status last verified
May 2018
First submitted
1 Jul 2015
Last updated
16 May 2018
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Otani PT, Rached RDVA, Alfieri FM, de Azevedo Neto RS, Hsing WT, Battistella LR, Imamura M. Ultrasound-guided suprascapular nerve block with lidocaine vs. saline combined with physical exercises for the rehabilitation of supraspinatus tendinitis: a randomized double-blind controlled trial. Front Pain Res (Lausanne). 2024 Nov 12;5:1490320. doi: 10.3389/fpain.2024.1490320. eCollection 2024.

    PubMed 39600565

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Lidocaine, Saline solution and Homemade exercises in people with Rotator Cuff Syndrome, run by Marta Imamura at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 22 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in the score of pain and function as assessed by Shoulder Pain and Disability Index (SPADI) (time frame: Baseline and one week after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02495818, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in